AGREGEX

Brand name authorized in: Cyprus Poland Tunisia

Active ingredients

The drug AGREGEX contains one active pharmaceutical ingredient (API):

1 Clopidogrel
UNII A74586SNO7 - CLOPIDOGREL

Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation.

Read about Clopidogrel

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Clopidogrel
B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC04

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
PL
Rejestru Produkt├│w Leczniczych
Identifier(s): 100220974, 100355817, 100358951, 100368458, 100377983, 100385184, 100417694, 100447608
TN
Direction de la Pharmacie et du M├ędicament
Identifier(s): 10243101